pone.0261641.s005.pdf (3.67 MB)
S2 File -
journal contribution
posted on 2022-01-31, 18:31 authored by Alexey Rzhevskiy, Andrei Popov, Chavdar Pavlov, Yuri Anissimov, Andrei Zvyagin, Yotam Levin, Efrat Kochba(PDF)
History
Usage metrics
Categories
Keywords
subsequent significant reductionsignificant side effectspoint likert scalepatient enrollment begannanopass technologies ltdmedian cubital veinsignificant pain reductionperipheral intravenous cannulation100 956cannulation site priorcontrolled clinical triallidocaine injection comparedinjected intradermally usinglidocaine injection usinginjected intradermallyinjection siteinjected usingclinical triallidocaine injectionnoticeable paininduced painexperienced paincannulation withoutlidocaine hydrochlorideintradermal injectionxlink ">superficial pinskin numbnesssecondary variablesecond groupright armresearchregistry4662 ).registration identifierrandomly allocatedprimary variableleft armlabel placebofirst groupeighty percentcommon proceduresachieved due45 minutes3 centimeters27g needle18g cannula005 ).
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC